Issue 4/2013

  • Big players rock bioplastics market

    In this issue:

    A major boost to the market for biopolymers
    A comprehensive new study shows that biobased precursor compounds used in plastics are finally beginning to come into their own. With support from some of the planet's biggest manufacturers, production worldwide is expected to triple within the next seven years. Much of the new production capacity will be created in Asia and South America, where cheap sugar feedstocks are easier to come by than in Europe or the US. The steadily expanding bioplastics pie, however, looks big enough for all.

    Volume 2015

    Volume 2014

    Volume 2013

    Volume 2012

    © 2007-2015 BIOCOM


    Alle Kurse


    • NORDIC NANOVECTOR (N)24.00 NOK23.71%
    • TRANSGENE (F)4.72 EUR23.56%
    • BAVARIAN NORDIC (D)41.03 EUR20.85%


    • THROMBOGENICS (B)3.09 EUR-20.97%
    • ZELTIA (E)3.35 EUR-12.76%
    • OXFORD BIOMEDICA (UK)8.00 GBP-12.09%


    • KARO BIO (S)38.50 SEK2383.9%
    • TRANSGENE (F)4.72 EUR63.9%
    • BIOTECH PHARMACON (N)12.50 NOK33.7%


    • THROMBOGENICS (B)3.09 EUR-42.4%
    • WILEX (D)2.05 EUR-41.4%
    • BIONOR PHARMA (N)1.26 NOK-39.4%


    • KARO BIO (S)38.50 SEK4595.1%
    • ADOCIA (F)87.65 EUR439.1%
    • GALAPAGOS (B)54.02 EUR324.7%


    • CHRONTECH PHARMA (S)0.01 SEK-85.7%
    • BIOTEST (D)19.84 EUR-76.1%
    • NEOVACS (F)0.89 EUR-74.9%

    No liability assumed, Date: 27.08.2015